Adicet Bio (ACET) Stock Price, Quote, News & History | Benzinga

Adicet Bio Inc (ACET) Stock Price, Quote, News & History

ACETNASDAQ

Trade with Public

Trade with Public

$8.26

0.030.36%

Last update: Aug 12, 7:54 PM

$8.36

0.131.58%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$8.30

Close

$8.26

Volume / Avg.

39.85K / 97.82K

Day Range

$8.18 - $8.35

52 Wk Range

6.01 - 17.44

Market Cap

$78.26M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

4.26%

Days to Cover

4.32

Recent ADICET Bio, Inc. News

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.

Vandana Singh

What's Going On With Adicet Bio Stock Today?

Shares of Adicet Bio are trading lower after the clinical stage biotechnology company announced a one-for-16 reverse stock split.

Alex Perry

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $80 million to fund Phase 2.

Vandana Singh

Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-84.53M

Investing Cash Flow (TTM)

7.83M

Financing Cash Flow (TTM)

75.08M

Free Cash Flow (TTM)

-84.97M

Capital Expenditure (TTM)

-438.00K

Net Change in Cash (TTM)

-1.62M

Analyst Trends and Forecast

2

Mar

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$28.06M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.64

Earnings Yield % (TTM)

-126.23%

Earnings Yield % (FWD)

-91.94%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$12.83

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$33.13M

Debt to Equity

0.11

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$8.30

Close

$8.26

Volume / Avg.

39.85K / 97.82K

Day Range

$8.18 - $8.35

52 Wk Range

6.01 - 17.44

Market Cap

$78.26M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

4.26%

Days to Cover

4.32

About

Sector

Health Care

Industry

Biotechnology

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Adicet Bio (ACET) stock?

A

You can purchase shares of Adicet Bio (NASDAQ:ACET) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Adicet Bio (ACET) competitors?

A

Other companies in Adicet Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Adicet Bio (ACET) stock?

A

Adicet Bio has a consensus price target of $24.63.

Q

What is the current price for Adicet Bio (ACET)?

A

The stock price for Adicet Bio (NASDAQ: ACET) is $8.36 last updated August 12, 2026 at 7:54 PM EDT.

Q

Does Adicet Bio (ACET) pay a dividend?

A

There are no upcoming dividends for Adicet Bio.

Q

When is Adicet Bio (NASDAQ:ACET) reporting earnings?

A

Adicet Bio does not have any upcoming earnings scheduled.

Q

Is Adicet Bio (ACET) going to split?

A

There is no upcoming split for Adicet Bio.

Q

What sector and industry does Adicet Bio (ACET) operate in?

A

Adicet Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.